Biontech wants to deliver its corona vaccine, which has been adapted to the Omicron variant, within a few days of the approval by the European Medicines Agency EMA, which is expected shortly. “We can deliver very promptly, hopefully from the beginning of September,” company boss Ugur Sahin told the “Spiegel”.
The EMA recently announced that the responsible committee wants to decide on the applications from Biontech/Pfizer and the US company Moderna for approval of their vaccines adapted to the subtype BA.1 on September 1st. In Germany, this variant no longer plays a role. The hope is that this vaccine will also work better against the currently circulating variants.
The EMA is also currently testing a corona vaccine from the Mainz-based company and its US partner Pfizer that has been adapted to the current Omikron variants BA.4 and BA.5. Biontech is currently submitting the last documents to the EMA, Sahin told the “Spiegel”: “Then things can go quickly here too.”
